Skip to main content

Advertisement

Table 2 Incidence and multiplicity of gastric tumors in MNU-treated mice

From: Gene expression analysis of a Helicobacter pylori-infected and high-salt diet-treated mouse gastric tumor model: identification of CD177 as a novel prognostic factor in patients with gastric cancer

Group Effective number Treatment Incidence (%) Multiplicity (no. of tumor/mouse)
Adenoma Carcinoma Total tumor Adenoma Carcinoma Total tumor
A 21 MNU 3(14.3) 13(61.9) 13(61.9) 0.1 ± 0.4a 0.8 ± 0.7 0.9 ± 0.8
B 4 MNU + H. pylori 4(100)b 4(100) 4(100) 1.5 ± 0.6 1.8 ± 1.0 3.3 ± 1.0c
C 14 MNU + 10% NaCl 2(14.3) 6(42.9) 7(50.0) 0.2 ± 0.6 0.8 ± 1.0 1.0 ± 1.2
D 9 MNU + H. pylori + 10% NaCl 4(44.4) 8(88.8) 9(100)d 0.4 ± 0.5e 2.1 ±1.4d 2.6 ± 1.1d
  1. Values for multiplicity are expressed as means ± SD. Incidences were generally assessed by Chi-square test, followed by pairwise analysis with Bonferroni correction. Multiplicities were generally analyzed by ANOVA, followed by the Tukey test for multiple comparison. a P < 0.01 vs. Group B, b P < 0.01 vs. Group A, c P < 0.05 vs. Group A, d P < 0.05 vs. Group C, e P <0.05 vs. Group B.